The annual report, which analyses drug spending trends for 11 publicly funded plans, showed a $1-billion spike in prescription drug spending during the 2015-2016 period. That brought total documented expenditures up to $11.3 billion, 79.7% of which was covered by the plans. The rest was paid by beneficiaries either out-of-pocket or through private drug plans.
Plan costs to rise 130% by 2025
Mercer, a global consulting company, today predicted that employers’ health benefit costs will increase by 130% by 2025 due to expensive specialty drugs, higher rates of chronic and mental illness, increased fraud and rising health pooling costs.
Hep C drugs covered by Ontario Trillium Drug Plan
Coverage for Hepatitis C Medications
The Ontario Drug Benefit Program (ODB) and the Trillium Drug Program (TDP)are the two main programs that assist Ontario residents with covering the costs of expensive prescription drugs and may be able to help cover the high cost of hepatitis C treatment medications.
